Decarboxylase inhibitors for treating Parkinson's disease

US12162902B2 · kind B2 · utility

Assignee

• Sail Biomedicines · US

Inventors

• Devin Forest Reed DOUD · Arlington, US
• Timothy F. BRIGGS · Waltham, US
• Steven John Taylor · Winchester, US
• Elijah Lane BOGART · Cambridge, US
• John Proudfoot · Newtown, US
• Dinara GUNASEKERA · Cambridge, US
• Spencer Cory PECK · Watertown, US
• Angela She · Waltham, US
• William T. McElroy · Plainfield, US
• Bernard LANTER · Somerville, US
• Michael Rutlin · Brookline, US

Key dates

• Filing date: Dec 6, 2019
• Grant date: Dec 10, 2024
• Expiry date: Aug 2, 2041

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Provided are inhibitors of pathogenic, bacterial metabolite production and conjugates of the inhibitors. Also provided are pharmaceutical compositions containing the inhibitors or conjugates and methods of using the same.